Micron Technology, Inc. Reports Results for the First Quarter of Fiscal 2026

(NASDAQ:MU), BOISE, Idaho, Dec. 17, 2025 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) today announced results for its first quarter of fiscal 2026, which ended November 27, 2025. Fiscal Q1 2026 highlights Revenue of $13.64 billion versus $11.32 billion for the prior quarter and $8.71 billion for the same period last year GAAP net […]

VITEC and Actelis Networks Announce Partnership to Bring IPTV to RF-Only Facilities

(NASDAQ:ASNS), Paris, France and Sunnyvale, Calif, Dec. 17, 2025 (GLOBE NEWSWIRE) — VITEC, a global leader in IPTV and digital signage solutions, and Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT applications, today announced a new partnership to deliver IPTV and digital signage to facilities operating

Redaptive Closes Approximately $216 Million Financing for First-of-its-Kind Securitization Backed by Energy-as-a-Service Performance Contracts

Private placement arranged by Deutsche Bank and backed by long-term Energy-as-a-Service contracts with Fortune 500 commercial and industrial customers Redaptive, the pioneer of infrastructure monetization, today announced the successful close of an inaugural Energy-as-a-Service asset-backed securitization with performance contracts from Fortune 500 commercial and industrial assets. The transaction, structured and underwritten by Deutsche Bank Securities

Insmed Provides Clinical and Business Update

Phase 2b BiRCh Study of Brensocatib in CRSsNP Did Not Meet Primary or Secondary Efficacy Endpoints; Safety Consistent with Previous Studies; Insmed Discontinues CRSsNP Program- Company Acquires Phase 2 Ready Monoclonal Antibody for Potential Respiratory and Immunological & Inflammatory Indications- Insmed Incorporated (Nasdaq:INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies

Scholastic Corporation Announces Third Quarter Dividend

Scholastic Corporation (NASDAQ: SCHL) announced today that its Board of Directors declared a quarterly cash dividend of $0.20 per share on the Company's Class A and Common Stock for the third quarter of fiscal 2026. The dividend is payable on March 16, 2026, to all shareholders of record as of the close of business on

Peregrine Energy Solutions Partners with Wärtsilä, WHC, and a Fortune 500 Company to Deliver 500MWh Grid Scale Energy Storage Project Project Just Outside Dallas – Fort Worth

Peregrine Energy Solutions LLC (Peregrine), an integrated clean-energy platform focused on utility-scale battery storage, announced today that it is advancing construction of the Mallard Energy Storage (Mallard) project, 30 miles Northeast of Dallas. The 250 MW / 500 MWh installation is a key step in Peregrine's rapid buildout of next-generation grid infrastructure across ERCOT. https://mma.prnewswire.com/media/2196305/PeregrineEnergySolutions_Logo.jpg

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Blue Owl, Gauzy, and Alexandria Real Estate and Encourages Investors to Contact the Firm

(NYSE:OWL),(NasdaqGM:GAUZ),(NYSE:ARE), NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Blue Owl Capital, Inc. (NYSE:OWL), Gauzy Ltd (NASDAQ:GAUZ), and Alexandria Real Estate Equities, Inc. (NYSE:ARE). Stockholders have until the deadlines below

Crane Harbor Acquisition Corp. II Completes Upsized $345 Million Initial Public Offering

(NASDAQ:CRAN),(NASDAQ:CRANU),(NASDAQ:CRANR), PHILADELPHIA, PA, Dec. 17, 2025 (GLOBE NEWSWIRE) — Crane Harbor Acquisition Corp. II (NASDAQ:CRANU) (the “Company”) today announced the closing of its upsized initial public offering of 34,500,000 units, which includes 4,500,000 units issued pursuant to the exercise by the underwriters of their over-allotment option in full. The offering was priced at $10.00 per

Inventiva to Present at the 44th Annual J.P. Morgan Healthcare Conference

(Paris:IVA), Daix (France), New York City (New York, United States), December 17, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of oral therapies for the treatment of metabolic dysfunction-associated steatohepatitis (“MASH”), today announced that CEO Andrew Obenshain has been invited to present a

Micron Technology, Inc. Reports Results for the First Quarter of Fiscal 2026

Micron Technology, Inc. Reports Results for the First Quarter of Fiscal 2026 AI demand acceleration and Micron execution drive record fiscal Q1 results, including highest ever free cash flow GlobeNewswire December 17, 2025 BOISE, Idaho, Dec. 17, 2025 (GLOBE NEWSWIRE) — Micron Technology, Inc. (Nasdaq: MU) today announced results for its first quarter of fiscal

Scroll to Top